In summary, Erzhi pills ameliorate cognitive dysfunction and alter pathological features of the hippocampus by regulating oestrogen levels and proteomic profiles and then activating the PI3K/Akt signalling pathway in AD rats induced by ovariectomy combined with d-galactose and Aβ1-40 injection. This evidence concerns the gene AKT1 and Alzheimer disease.